Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2000
02/10/2000WO2000006572A1 Bensoquinolizine derivatives and process for producing the same
02/10/2000WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same
02/10/2000WO2000006570A1 Triazolopyridines for the treatment of thrombosis disorders
02/10/2000WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000WO2000006568A1 Substituted pyrazole derivatives
02/10/2000WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine
02/10/2000WO2000006564A1 Disubstituted maleimide compounds and medicinal utilization thereof
02/10/2000WO2000006556A1 Substituted oxazolines as antiproliferative agents
02/10/2000WO2000006545A1 High affinity ligands for nociceptin receptor orl-1
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006525A2 Synthesis of combinatorial libraries of compounds reminiscent of natural products
02/10/2000WO2000006173A1 5-ht1f agonists
02/10/2000WO2000006169A1 Integrin receptor antagonists
02/10/2000WO2000006082A2 Treatment of anxiety disorders
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000DE19834940A1 New photochromic spiro compounds used with preferably polythiourethane matrix in phototropic glass, preferably for ophthalmologic applications, and optical measuring, recording and storage matrix are e.g. spiro(fluorene-pyrrolophthalazines)
02/10/2000CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000CA2338912A1 Medicine nitrate salts
02/10/2000CA2338866A1 Disubstituted maleimide compound and pharmaceutical use thereof
02/10/2000CA2338740A1 Treatment of anxiety disorders
02/10/2000CA2338654A1 Triazolopyridines for the treatment of thrombosis disorders
02/10/2000CA2338275A1 Integrin receptor antagonists
02/09/2000EP0978516A1 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase iv inhibitory activity
02/09/2000EP0978514A1 Indazole derivatives as 5-HT1F agonists
02/09/2000EP0978392A1 Optical recording media
02/09/2000EP0978280A1 2-azabicyclo compounds
02/09/2000EP0977757A1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
02/09/2000EP0977755A1 Heterocyclic compounds and their preparation and use
02/09/2000EP0977754A1 Writable and erasable high-density optical storage media
02/09/2000EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation
02/09/2000EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds
02/09/2000EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response
02/09/2000CN1244193A Novel amide derivatives and medicinal compositions thereof
02/09/2000CN1243829A Cationic polypeptide condensing agent of thiazole, its synthesizing process and its application
02/09/2000CN1243828A Cationic polypeptide condensing agent of pyridine, its synthesizing process and its application
02/08/2000US6022970 Process for preparing 2-anilinoacridones
02/08/2000US6022884 Substituted pyridine compounds and methods of use
02/08/2000CA2150016C Pyrrolopyrimidines as crf antagonists
02/08/2000CA2014379C Compounds
02/08/2000CA2004597C Topical formulations and transdermal delivery systems containing 1-isobutyl-1h-imidazo-[4,5-c]quinoline-4-amine
02/03/2000WO2000005232A1 Heterocyclic compounds as inhibitors of rotamase enzymes
02/03/2000WO2000005231A1 Fkbp inhibitors
02/03/2000WO2000005230A1 Pyrazole derivatives and salts thereof
02/03/2000WO2000005221A1 Substituted benzoylcyclohexandiones
02/03/2000WO2000004905A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
02/03/2000WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
02/03/2000WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
02/03/2000DE19834751A1 Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel Disubstituted bicyclic heterocycles, their preparation and their use as medicaments
02/03/2000DE19834047A1 Substituierte Pyrazolderivate Substituted pyrazole derivatives
02/03/2000DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine
02/03/2000DE19834044A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
02/03/2000CA2338304A1 Substituted benzoylcyclohexandiones
02/03/2000CA2338222A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
02/02/2000EP0976749A1 Process for preparing quinolone and naphthyridone carboxylic acids
02/02/2000EP0976747A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders
02/02/2000EP0975639A1 Compounds
02/02/2000EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds
02/02/2000EP0975632A1 Alkaloid halide salts of swainsonine and methods of use
02/02/2000EP0975602A1 Imidazole and imidazoline derivatives and uses thereof
02/02/2000CN1243514A Sulfonamide derivatives
02/02/2000CN1243513A Quinoline and quinozoline compounds useful in therapy, particularly in the theatment of begnin prostatic hyperplasia
02/02/2000CN1048986C Heterocyclic compounds and their preparation and use
02/01/2000US6020492 Deazapurine derivatives; a new class of CRF1 specific ligands
02/01/2000US6020368 Microbiocides
02/01/2000US6020343 (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
02/01/2000US6020342 Fused imidazo[1,2-A]pyridines
02/01/2000US6020340 Imidazopyridines
02/01/2000US6020335 (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
01/2000
01/27/2000WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000WO2000004019A1 5-bicycloindole compounds
01/27/2000WO2000003997A1 Thiobenzimidazole derivatives
01/27/2000WO1999063930A3 Novel angiotensin receptor modulators and their uses
01/27/2000CA2343748A1 5-bicycloindole compounds
01/27/2000CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/26/2000EP0974592A1 Novel processes for producing pyridoindole derivatives
01/26/2000EP0973773A1 Pyrimido-isoquinoline compounds with anticonvulsive action
01/26/2000EP0973772A1 Compounds
01/26/2000EP0973752A1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
01/26/2000EP0973727A2 Activated iododerivatives for the treatment of cancer and aids
01/26/2000EP0973513A1 Compositions and methods for treating bone deficit conditions
01/26/2000EP0973396A1 A method of treating cancer
01/26/2000EP0973395A1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
01/26/2000CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
01/26/2000CN1242366A Diaza-spiro [3,5] nonane derivatives
01/26/2000CN1048730C Zinc pipemidic, process for synthesizing same, and ointment contg. same
01/26/2000CN1048729C Novel process for prepn. of anti-ulcer agent
01/26/2000CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof
01/25/2000US6018054 Intermediate compounds for preparing novel quinolone and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, use as antibacterial agents and as feed additives
01/25/2000US6018046 Pyridocarbazole derivatives having cGMP-PDE inhibitory activity
01/25/2000US6017927 Quinuclidine derivatives and medicinal composition thereof
01/25/2000US6017926 Integrin receptor antagonists
01/25/2000US6017925 Integrin antagonists
01/25/2000US6017924 Androgen receptor modulator compounds and methods
01/25/2000US6017910 PCP receptor ligands and the use thereof
01/20/2000WO2000002879A1 Lk6-a derivatives
01/20/2000WO2000002878A1 Compounds having activity at imidazoline receptors